المؤلفون: González-Álvaro, Isidoro, Martínez-Fernández, Carmen, Dorantes-Calderón, Benito, García-Vicuña, Rosario, Hernández-Cruz, Blanca, Herrero-Ambrosio, Alicia, Ibarra-Barrueta, Olatz, Martín-Mola, Emilio, Monte-Boquet, Emilio, Morell-Baladrón, Alberto, Sanmartí, Raimon, Sanz-Sanz, Jesús, De-Toro, Javier, Vela, Paloma, Román Ivorra, José Andrés, Poveda-Andrés, José Luis, Muñoz-Fernández, Santiago

مصطلحات موضوعية: Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondolytis, Biologics, Optimization, Dose reduction, bDMARD, cDMARD, Risk/benefit ratio

العلاقة: http://dx.doi.org/10.1093/rheumatology/keu461Test; González-Álvaro I, Martínez-Fernández C, Dorantes-Calderón B, et al. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Rheumatology (Oxford). 2015;54(7):1200-1209.; http://hdl.handle.net/2183/14871Test

الإتاحة: https://doi.org/10.1093/rheumatology/keu461Test
http://hdl.handle.net/2183/14871Test

المؤلفون: Raimon Sanmartí, Jesús Sanz-Sanz, Rosario García-Vicuña, Benito Dorantes-Calderón, Carmen Martinez-Fernandez, Paloma Vela, Isidoro González-Álvaro, José Andrés Román Ivorra, José Luis Poveda-Andrés, Olatz Ibarra-Barrueta, Santiago Muñoz-Fernández, Emilio Martín-Mola, Blanca Hernández-Cruz, Alberto Morell-Baladrón, Alicia Herrero-Ambrosio, Emilio Monte-Boquet, Francisco Javier de Toro-Santos

المساهمون: [Gonzalez-Alvaro, Isidoro, Garcia-Vicuna, Rosario] Hosp Univ La Princesa, Inst Invest Sanitaria La Princesa, Rheumatol Serv, Madrid 28006, Spain, [Herrero-Ambrosio, Alicia] IdiPaz, Hosp Univ La Paz, Hosp Pharm Serv, Madrid, Spain, [Martin-Mola, Emilio] Univ Autonoma Madrid, IdiPaz, Hosp Univ La Paz, Rheumatol Serv, Madrid, Spain, [Morell-Baladron, Alberto] Hosp Univ La Princesa, Hosp Pharm Serv, Madrid 28006, Spain, [Sanz-Sanz, Jesus] Hosp Puerta de Hierro, Rheumatol Serv, Madrid, Spain, [Munoz-Fernandez, Santiago] Univ Europea Madrid, Hosp Univ Infanta Sofia, Rheumatol Serv, Madrid, Spain

المصدر: Rheumatology (Oxford, England)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
RUC. Repositorio da Universidade da Coruña
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Optimization, rheumatoid arthritis, medicine.medical_specialty, bDMARD, Delphi method, Dose reduction, Pharmacy, Biologics, Arthritis, Rheumatoid, Psoriatic arthritis, Tratamiento médico, Rheumatology, Risk–benefit ratio, Internal medicine, ankylosing spondylitis, medicine, Humans, Pharmacology (medical), Spondylitis, Ankylosing, biologics, Hospital pharmacy, Rheumatoid arthritis, risk/benefit ratio, Intensive care medicine, psoriatic arthritis, Ankylosing spondylitis, Biological Products, Medicamento, Dose-Response Relationship, Drug, business.industry, Arthritis, Psoriatic, Sociedad Española de Farmacia Hospitalaria, Clinical Science, medicine.disease, Ankylosing spondolytis, Systematic review, dose reduction, Sociedad Española de Reumatología, Physical therapy, cDMARD, business, Enfermedad, optimization, Reumatismo, Risk/benefit ratio

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1921c7ea66bc4d43aa73edcdb91f2465Test
https://pubmed.ncbi.nlm.nih.gov/25526976Test

مصطلحات الفهرس: Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondolytis, Biologics, Optimization, Dose reduction, bDMARD, cDMARD, Risk/benefit ratio, info:eu-repo/semantics/article

URL: http://hdl.handle.net/2183/14871Test
http://dx.doi.org/10.1093/rheumatology/keu461Test